The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
about
Nuclear factor-kappa B1 inhibits early apoptosis of glioma cells by promoting the expression of Bcl-2ICG-001 affects DRP1 activity and ER stress correlative with its anti-proliferative effect.Signaling pathways and mesenchymal transition in pediatric high-grade glioma.Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutSα interaction
P2860
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The β-catenin/CBP-antagonist I ...... y in a Wnt-independent manner.
@en
type
label
The β-catenin/CBP-antagonist I ...... y in a Wnt-independent manner.
@en
prefLabel
The β-catenin/CBP-antagonist I ...... y in a Wnt-independent manner.
@en
P2093
P2860
P50
P356
P1433
P1476
The β-catenin/CBP-antagonist I ...... y in a Wnt-independent manner.
@en
P2093
Christof M Kramm
Christopher Diederichs
Fabian Schill
Gabriela Salinas
Maria Wiese
Neele Walther
Sebastian Monecke
P2860
P304
27300-27313
P356
10.18632/ONCOTARGET.15934
P407
P577
2017-04-01T00:00:00Z